Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More

Procter & Gamble (NYSE:PG | PG Price Prediction) is facing fresh analyst pressure as TD Cowen cut its price target to $142 from $156, maintaining a Hold rating. The firm’s thesis centers on oil-related input cost inflation tied to the Iran war, a headwind it believes P&G and its peers cannot fully absorb.

With shares trading near $144.72, TD Cowen’s new target implies the stock has limited upside from current levels. PG is up just 2.07% so far this year, after shares lost 11.49% over the past month.

The Analyst’s Case

TD Cowen reduced estimates across the household and personal care space, arguing that companies will be unable to fully mitigate higher oil-related input costs stemming from the Iran war. Critically, the firm warns that even a swift resolution to the conflict won’t reverse the damage — price increases “will prove sticky due to infrastructure damage.” TD Cowen also flags declining pricing power relative to history and less opportunity to trade up consumers to super-premium products as compounding factors.

That last point matters. P&G’s premiumization strategy has been a key margin lever, but if consumers are already stretched, moving them toward higher-priced SKUs becomes structurally harder. The firm’s concerns align with what P&G’s own results already show: core gross margin contracted 50 basis points in Q2 FY2026, with tariff costs delivering a 60 bps headwind even as productivity savings offset some pressure.

What the Numbers Show

P&G’s Q2 FY2026 results captured the tension well. Core EPS came in at $1.88, beating the consensus estimate of $1.8569, but net sales of $22.21 billion missed the $22.29 billion estimate. More telling: operating income fell 6.53% year-over-year to $5.366 billion, and net income dropped 6.72% to $4.319 billion. The EPS beat was driven by cost discipline, not revenue momentum, a distinction that matters when input costs are rising.

Management has guided for approximately $400 million in after-tax tariff costs for FY2026 and maintained its core EPS range of $6.83–$7.09. But holding that guidance requires productivity gains and pricing to keep pace — execution risk that TD Cowen appears unwilling to price optimistically.

Why the Move Matters Now

TD Cowen’s $142 target sits well below the consensus analyst price target of $167.59 and represents a meaningful divergence from the broader Street view of 14 Buy ratings versus nine Holds and one Sell. The stock has already pulled back sharply, down 13.44% over the past month from $167.20. Deutsche Bank also trimmed its target to $162 from $171, and Erste Group downgraded the stock from Buy to Hold citing cost pressures and weak consumer demand.

What Investors Should Watch

P&G remains a Dividend King in its 69th consecutive year of dividend increases, with a quarterly dividend of $1.0568 per share and a trailing yield near 2.93%. For income-focused investors, that consistency carries weight. But TD Cowen’s warning about sticky input cost inflation and eroding pricing power signals that margin recovery may be slower than the current guidance implies. The next major read comes at P&G’s Q3 earnings webcast on April 24, 2026 — a key test of whether management’s optimism holds.